Pharming Group NV PHAR Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	54,62M	42,54M	54,9M	66,66M	81,22M	55,59M	74,09M	74,85M
Reddito operativo	-39,05M	-14M	-4,81M	1,42M	-30,12M	-16,85M	-3,42M	3,67M
Reddito ante imposte	-18,08M	-16,67M	3,39M	3,31M	-2,03M	-16,62M	-60k	1,51M
Reddito netto	-14,63M	-12,21M	1,32M	3,46M	-2,69M	-12,45M	-1,22M	-1,03M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-39,05M	-14M	-4,81M	1,42M	-30,12M	-16,85M	-3,42M	3,69M
EBITDA	-39,05M	-14M	656k	-4,05M	-30,12M	-16,85M	2,21M	3,67M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	13,69M	89,62M	135,13M	169,02M	212,17M	198,87M	205,62M	245,32M
Reddito operativo	-11,54M	21,91M	39,6M	61,14M	76,62M	14,26M	17,09M	-5,68M
Reddito ante imposte	-17,54M	-85,69M	857k	46,68M	44,09M	23,08M	14,99M	-12,01M
Reddito netto	-17,54M	-76,25M	24,99M	36,2M	37,75M	16M	13,67M	-10,55M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.038	-0.132	0.04	0.057	0.059	0.025	0.01	-0.008
UTILE OPERATIVO	-11,54M	-30,2M	39,6M	61,14M	76,62M	14,26M	17,09M	-5,68M
EBITDA	-10,49M	25,81M	47,41M	66,78M	85,57M	34,93M	30,98M	10,25M